Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | CNR2 | P34972 | 9/20 | 0.37 |
| ▸ | CNR1 | P21554 | 7/20 | 0.37 |
| ▸ | PPARG | P37231 | 1/20 | 0.34 |
| ▸ | PPARD | Q03181 | 1/20 | 0.34 |
| ▸ | PPARA | Q07869 | 1/20 | 0.34 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4116171 | 1.00 | ALDH1A1 (0.43) | ALDH1A1CNR2CNR1PPARGPPARD | |
| SCHEMBL10021980 | 0.79 | ALDH1A1 (0.45) | ALDH1A1CNR2CNR1PPARGPPARD | |
| Potassium Ion SCHEMBL2563941 | 0.78 | ALDH1A1 (0.39) | ALDH1A1CNR2CNR1PPARGPPARD | |
| Potassium Ion SCHEMBL2563944 | 0.78 | ALDH1A1 (0.39) | ALDH1A1CNR2CNR1PPARGPPARD | |
| Bicarbonate SCHEMBL7227147 | 0.77 | ALDH1A1 (0.47) | ALDH1A1CNR2CNR1PPARGPPARD | |
| Bicarbonate SCHEMBL11119970 | 0.77 | ALDH1A1 (0.47) | ALDH1A1CNR2CNR1PPARGPPARD | |
| SCHEMBL17225894 | 0.77 | TSHR (0.44) | ALDH1A1CNR2CNR1PPARGPPARD | |
| SCHEMBL9724372 | 0.77 | ALDH1A1 (0.43) | ALDH1A1CNR2CNR1PPARGPPARD | |
| SCHEMBL13604747 | 0.77 | ALDH1A1 (0.43) | ALDH1A1CNR2CNR1PPARGPPARD | |
| Sorbic Acid SCHEMBL19555674 | 0.77 | TSHR (0.44) | ALDH1A1CNR2CNR1PPARGPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090076136-A1 | THERAPEUTIC AGENT | ENOKI TATSUJI | 2009-03-19 | — | — | US | disclosed |
| US-20070060641-A1 | Therapeutic agent | TAKARA BIO INC. (JP) | 2007-03-15 | — | — | US | disclosed |
| EP-1627632-A1 | THERAPEUTIC AGENT | TAKARA BIO INC. (JP) | 2006-02-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090076136-A1 | THERAPEUTIC AGENT | GPR119, IAPP, FABP4 | ALDH1A1 1487/4885CNR2 3951/4885CNR1 3304/4885 |
| US-20070060641-A1 | Therapeutic agent | GPR119, IAPP, FABP4 | ALDH1A1 1487/4885CNR2 3951/4885CNR1 3304/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.